Skip to content

Clinical trials

Recruiting Esophageal Squamous Cell Carcinoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Squamous Cell Carcinoma Status: Recruiting Country / region: United States Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20191
20203
20211
20221
20234
20247
202510
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting35

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC3
City of Hope Medical Center2
IDEAYA Biosciences2
Seagen, a wholly owned subsidiary of Pfizer2
ALX Oncology Inc.1
AbbVie1
Alentis Therapeutics AG1
Astellas Pharma Global Development, Inc.1
AstraZeneca1
BeOne Medicines1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Squamous Cell Carcinoma35
Squamous Cell Carcinoma of Head and Neck18
Carcinoma, Non-Small-Cell Lung15
Colorectal Neoplasms10
Uterine Cervical Neoplasms9
Carcinoma, Hepatocellular8
Neoplasm Metastasis8
Stomach Neoplasms8
Esophageal Neoplasms7
Small Cell Lung Carcinoma7

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.